Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in ...

Videos circulating on social media appear to show Israeli air defence systems engaging incoming projectiles over central Israel during Iran’s latest ballistic missile launches, as tensions in the ...

PALO ALTO, Calif. & HONG KONG--(BUSINESS WIRE)--Mar 16, 2026-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer ...

First insurer in Asia to bring the innovative blood-based multi‑cancer screening solution to Hong Kong, Singapore, and the Philippines HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. Latin America Brief: Trump’s Summit Offers More ...

HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 /PRNewswire/ — Manulife today announced an exclusive partnership with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...